Kartagener SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Kartagener Syndrome
Sharon Dell practices practicing medicine in Vancouver, Canada. Dell is rated as an Elite expert by MediFind in the treatment of Kartagener Syndrome. They are also highly rated in 14 other conditions, according to our data. Their clinical expertise encompasses Ciliary Dyskinesia-Bronchiectasis, Drug Induced Dyskinesia, Situs Inversus, and Dextrocardia.
University Of North Carolina At Chapel Hill
Michael Knowles is a Pulmonary Medicine provider practicing medicine in Chapel Hill, North Carolina. Dr. Knowles is rated as an Elite provider by MediFind in the treatment of Kartagener Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Ciliary Dyskinesia-Bronchiectasis, Bronchiectasis, Cystic Fibrosis, Kartagener Syndrome, and Myringotomy.
Heymut Omran practices practicing medicine in Muenster, Germany. Omran is rated as an Elite expert by MediFind in the treatment of Kartagener Syndrome. They are also highly rated in 14 other conditions, according to our data. Their clinical expertise encompasses Situs Inversus, Ciliary Dyskinesia-Bronchiectasis, Kartagener Syndrome, and Drug Induced Dyskinesia.
Summary: Primary Ciliary Dyskinesias (PCD) are rare, autosomal recessive respiratory diseases, due to a defect in mucociliary clearance linked to abnormalities in the structure and/or function of the cilia. The variety of ciliary abnormalities identified reflects the genetic heterogeneity of PCDs. The thirty or so genes currently implicated explain the pathology in about half of the patients. PCDs are char...
Summary: The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center